Literature DB >> 19643165

Genetically modified mouse models for premature ovarian failure (POF).

Krishna Jagarlamudi1, Pradeep Reddy, Deepak Adhikari, Kui Liu.   

Abstract

Premature ovarian failure (POF) is a complex disorder that affects approximately 1% of women. POF is characterized by the depletion of functional ovarian follicles before the age of 40 years, and clinically, patients may present with primary amenorrhea or secondary amenorrhea. Although some genes have been hypothesized to be candidates responsible for POF, the etiology of most of the cases is idiopathic, with the underlying causes still unidentified because of the heterogeneity of the disease. In this review, we consider some mutant mouse models that exhibit phenotypes which are comparable to human POF, and we suggest that the use of these mouse models may help us to gain a better understanding of the molecular mechanisms underlying POF in humans. 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19643165     DOI: 10.1016/j.mce.2009.07.016

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  22 in total

1.  Ovarian abnormalities in a mouse model of fragile X primary ovarian insufficiency.

Authors:  Gloria E Hoffman; Wei Wei Le; Ali Entezam; Noriyuki Otsuka; Zhi-Bin Tong; Lawrence Nelson; Jodi A Flaws; John H McDonald; Sanjeeda Jafar; Karen Usdin
Journal:  J Histochem Cytochem       Date:  2012-04-02       Impact factor: 2.479

2.  RanBPM is essential for mouse spermatogenesis and oogenesis.

Authors:  Sandrine Puverel; Colleen Barrick; Susanna Dolci; Vincenzo Coppola; Lino Tessarollo
Journal:  Development       Date:  2011-05-11       Impact factor: 6.868

3.  FOXL2 interacts with steroidogenic factor-1 (SF-1) and represses SF-1-induced CYP17 transcription in granulosa cells.

Authors:  Mira Park; Eunkyoung Shin; Miae Won; Jae-Hong Kim; Hayoung Go; Hyun-Lee Kim; Jeong-Jae Ko; Kangseok Lee; Jeehyeon Bae
Journal:  Mol Endocrinol       Date:  2010-03-05

4.  Homozygous loss-of-function mutations in SOHLH1 in patients with nonsyndromic hypergonadotropic hypogonadism.

Authors:  Yavuz Bayram; Suleyman Gulsuner; Tulay Guran; Ayhan Abaci; Gozde Yesil; Hilal Unal Gulsuner; Zeynep Atay; Sarah B Pierce; Tomasz Gambin; Ming Lee; Serap Turan; Ece Bober; Mehmed M Atik; Tom Walsh; Ender Karaca; Davut Pehlivan; Shalini N Jhangiani; Donna Muzny; Abdullah Bereket; Atilla Buyukgebiz; Eric Boerwinkle; Richard A Gibbs; Mary-Claire King; James R Lupski
Journal:  J Clin Endocrinol Metab       Date:  2015-03-16       Impact factor: 5.958

5.  Prdm9 deficiency of rat oocytes causes synapsis among non-homologous chromosomes and aneuploidy.

Authors:  Srdjan Gasic; Ondrej Mihola; Zdenek Trachtulec
Journal:  Mamm Genome       Date:  2022-05-20       Impact factor: 2.957

Review 6.  RanBPM, a scaffolding protein for gametogenesis.

Authors:  Sandrine Puverel; Lino Tessarollo
Journal:  Curr Top Dev Biol       Date:  2013       Impact factor: 4.897

Review 7.  Cellular and molecular mechanisms of various types of oocyte aging.

Authors:  Toshifumi Takahashi; Hideki Igarashi; Mitsuyoshi Amita; Shuichiro Hara; Hirohisa Kurachi
Journal:  Reprod Med Biol       Date:  2011-07-02

8.  A Nuclear and Cytoplasmic Characterization of Bovine Oocytes Reveals That Cysteamine Partially Rescues the Embryo Development in a Model of Low Ovarian Reserve.

Authors:  Valentina Lodde; Alberto Maria Luciano; Giulia Musmeci; Ileana Miclea; Irene Tessaro; Mariella Aru; David F Albertini; Federica Franciosi
Journal:  Animals (Basel)       Date:  2021-06-29       Impact factor: 2.752

9.  Premature ovarian failure in mice with oocytes lacking core 1-derived O-glycans and complex N-glycans.

Authors:  Suzannah A Williams; Pamela Stanley
Journal:  Endocrinology       Date:  2011-01-14       Impact factor: 4.736

10.  The safe use of a PTEN inhibitor for the activation of dormant mouse primordial follicles and generation of fertilizable eggs.

Authors:  Deepak Adhikari; Nagaraju Gorre; Sanjiv Risal; Zhiyi Zhao; Hua Zhang; Yan Shen; Kui Liu
Journal:  PLoS One       Date:  2012-06-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.